Total Funding
36
1
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-64 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
639663
Neoclone is a research-focused company with an emphasis on emerging antibody technologies.
- Mark Sullivan: Director of Phage Technologies
- Rachel Kravitz: Director of Research
About the Company
Neoclone is a research-focused company with an emphasis on emerging antibody technologies. NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ways to discover and develop antibodies.
